GRIN1 and epilepsy: Genetic mutations in the NMDA receptors, such as GRIN1, GRIN2B, and GRIN2D, and mutations in the AMPA receptors, which increase AMPA expression, are suspected of contributing to physiological imbalances in epilepsy, remodeling and reconfiguring the neural networks.